From Name:
From Email:
To Name:
To Email:

Optional Message:


DiaMedica Therapeutics announces publication of a paper, 'Human Tissue Kallikrein in the Treatment of Acute Ischemic Stroke'

from DiaMedica Therapeutics via GlobeNewswire

DiaMedica Therapeutics Inc. announces the publication of a paper titled "Human Tissue Kallikrein In The Treatment Of Acute Ischemic Stroke" in the peer-reviewed journal, "Therapeutic Advances in Neurological Disorders." The paper summarizes the mechanistic rationale for using KLK1 to treat patients with acute ischemic stroke and summarizes human preclinical and clinical data supporting the hypothesis that KLK1 treatments may improve outcomes after AIS. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063